Trinean to enter into global supply agreement with QIAGEN
January 18, 2014
Gentbrugge – Trinean, the leading provider of microfluidic spectrophotometry platforms, today announced that it entered into a manufacturing and supply agreement with QIAGEN for the production of the QIAxpert, a micro-volume spectrometer for DNA and RNA quantitation and quality analysis. This platform is a UV/VIS spectrophotometer which contains tailor-made solution for QIAGEN customers using QIAGEN’s [...]
January 17, 2014
PARIS -- Cellectis (Paris:ALCLS): Axxam (Milan), a leading provider of discovery services including assay development for high-throughput screening, and Cellectis bioresearch (Paris), the cell engineering expert, have started a collaboration to offer to the Life Science industry an extensive range of integrated discovery services based on genomic engineering technologies. Under the joint offering, clients will [...]
Medicus Labs Acquires Latest Medical Technology in Mass Spectrometry Drug Detection
January 17, 2014
Dallas, Texas -- Medicus Labs announces the purchase of two AB SCIEX Triple Quad 5500 mass spectrometers for an undisclosed amount, as confirmed today by a company representative. The mission of Medicus Labs is to pioneer use of the industry’s most advanced technology in the field of toxicology analysis. The AB SCIEX Triple Quad 5500’s [...]
Life Technologies Introduces Its Most-Efficient, Versatile Reagent for Difficult-to-Transfect Cells
January 17, 2014
CARLSBAD, Calif. Life Technologies Corporation today announces the launch of Lipofectamine® 3000, the company’s most efficient and versatile transfection reagent for nucleic acid delivery in the broadest spectrum of cell lines. The product increases efficiency up to 10-fold in difficult-to-transfect cells, which is key for researchers working with more biologically relevant cell models. “Its superior [...]
IntelliCyt Corporation Announces First Reagent System for Multiplexed Screening of Secreted Proteins
January 17, 2014
Albuquerque, NM -- IntelliCyt Corporation, a provider of assay screening solutions for phenotypic drug discovery, antibody discovery and in vitro toxicity testing, today announced the MultiCyt™ QBeads™ PlexScreen family of reagents. It is the first commercially available product to enable multiplexed analysis of secreted proteins at the pace and price needed for screening and the [...]
Corning Showcases Expanded Drug Discovery Portfolio at SLAS 2014
January 17, 2014
CORNING, N.Y. – Corning Incorporated (NYSE: GLW) today announced its new Corning® 96- and 384-Well Spheroid Microplates and the Corning® High-Content Imaging Cyclic Olefin Copolymer (COC) Microplates. Corning Life Sciences will showcase its latest innovations in booth #1029 at the Society for Laboratory Automation & Screening (SLAS) 2014 Conference, Jan. 18-22, in San Diego, Calif. [...]
January 17, 2014
Agreement supports further development of organoids as next-generation drug screening platform Utrecht- The HUB Foundation for Organoid Technology announced today that it has signed a licensing agreement with STEMCELL Technologies Inc. for the manufacturing and worldwide distribution of cell culture media for growing Organoids. Organoids are mini-organs grown in tissue culture from small pieces of [...]
January 17, 2014
ALAMEDA, Calif. -- LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of LifeMap Discovery™ version 1.5 (discovery.lifemapsc.com). LifeMap Discovery™ is a state-of-the-art roadmap of embryonic development and stem cell biology. The product integrates embryonic development and stem cell biology, molecular, cellular, anatomical, and disease-related information, and provides data-mining [...]
January 17, 2014
ST. LOUIS -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that Sigma Life Science, its innovative biological products and services business, will be launching the genetically-modified HepaRG human liver cell line, licensed from Biopredic, for hepatotoxicity and drug metabolism assays. Currently undergoing beta-testing by multiple contract research and pharmaceutical organizations, the assays will be publicly available [...]
Innova Biosciences and TGR BioSciences Announce Co-Marketing Agreement for Core Technologies
January 16, 2014
Cambridge, UK and Adelaide, Australia,TGR BioSciences Pty Ltd (TGR), a life sciences company focused on the development of rapid, high sensitivity ELISA systems using their CaptSure technology, and Innova Biosciences (Innova), a specialist provider of bioconjugation systems, announced that they have entered into an agreement to promote and co-market each other’s highly complementary technologies, providing [...]

